Clinical Trial Update: The Effect of Galcanezumab-gnlm on Post-Traumatic, Migrainous Headaches [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating galcanezumab-gnlm for post-traumatic migrainous headaches has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Migraine
• Post-traumatic Headache

Drugs mentioned

• Galcanezumab-gnlm (galcanezumab-gnlm)

Snippet

Sponsor: Albany Medical College | Conditions: Post-Traumatic Headache | Phase 4 | Status: COMPLETED